Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Polycystic Ovary Syndrome (PCOS) is common in women with conditions like anovulation, hirsutism, hair loss, and type 2 diabetes, and it can lead to health risks like heart disease, obesity, insulin resistance, and depression. Non-Classic Congenital Adrenal Hyperplasia (NC-CAH) is also discussed.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Accurate assessment of puberty using Tanner staging is crucial for identifying normal and abnormal development.

Anti-androgens might help reduce COVID-19 severity in men.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Testosterone may both worsen and protect against COVID-19 effects in men.

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Mesenchymal stem cells could help treat diabetes and its complications by improving insulin function and reducing inflammation.

Three siblings with a genetic form of rickets showed different symptoms of the disease.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Children and adults with Cushing's disease show different symptoms and males have more severe cases; surgery outcomes can be predicted by certain factors.

Surgery removed an ovarian tumor, improving her symptoms and normalizing testosterone levels.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

The meeting presented new findings on hair stem cells, pigmentation, genetics, and modern hair treatment techniques.

Skin changes can reveal serious hormone-related diseases, helping save lives.

Physicians in China prioritize clinical hyperandrogenism in PCOS treatment, but clearer guidelines are needed.

The Bethesda system is effective for identifying thyroid cancer but has low sensitivity.

A new gene mutation causes insulin resistance in a girl and her mother.

Hyperandrogenism is diagnosed using clinical signs, lab tests, and imaging.

The International Society of Hair Restoration Surgery created a standard curriculum in 2008 to guide doctors in diagnosing and treating hair loss effectively.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Hirsutism and androgenetic alopecia in women are often due to increased androgen effects, and antiandrogen treatment is recommended to prevent further issues.

The questionnaire is valid and reliable but needs more testing for future predictions.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

The document concludes that AFA should be considered in patients with acromegaly-like features but normal hormone levels, and more cases need to be identified to understand the condition fully.

Women with hyperandrogenism, especially those with PCOS, are more likely to have psychiatric disorders.